We have a broad portfolio of products and product candidates, extensively covering in the areas of Cardiology, Diabetology and General commercial products in other therapeutic areas are also offered by the company to facilitate addressing serious medical needs. As part of our constant and resolute endeavour to bring solace to the lives of patients, we are continuing to broaden our diverse commercial product portfolio and our research and development in therapeutic areas that can leverage our unique expertise. We achieve this through a development policy of increasing sales of the existing medicines in our portfolio, acquiring commercial products or product candidates that are in late-stage development, and promoting steady development of our pipeline of manifold therapies.
Our extensive portfolio comprises of products targeting a wide spectrum of therapeutic areas. It covers medicinal products aimed at the treatment of infections, cardiovascular diseases, analgesics, drugs for the treatment of the diseases of the central nervous system, medicinal products aimed at women’s health, and drugs for the treatment of the digestive tract.
Cardiovascular Diseases
Women’s Health
Infections and Fungi
Central Nervous System
Gastrointestinal Diseases
Respiratory Diseases
Urology
Pain
Glimepiride 1mg + Metformin Hydrochloride PR 500 mg Tablets
Glimepiride 2mg + Metformin Hydrochloride PR 500 mg Tablets
Deflazacort 6 mg Tablets
Calcium Carbonate 1250 mg Eq. To. Elemental
Calcium 500 mg + Vitamin D3 1000 IU Tablets
Ferrous Ascorbate eq. to elemental Iron 100 mg + Folic Acid 1.5 mg + elemental Zinc 22.5 mg Tablets
Ondansetron 4 mg Tablets
Trypsin BP 48 mg + Bromelain 90 mg + Rutoside 100 mg Tablets
Cissus Quadrangularis 500 mg + Calcium Citrate Malate 500 mg + Vitamin D3 1000 IU Tablets
Aceclofenac 100 mg + Paracetamol 325 mg Tablets
Levocetirizine 5 mg + Montelukast 10 mg Tablets
Rebeprazole 20 mg Tablets
Rebeprazole 20 mg + Domperidone SR 30 mg Capsules
Copyright © 2018 Centrox Life Sciences. All Rights Reserved!